Abstract Introduction 65
The CDC biofilm reactor has been validated as a robust and repeatable reactor system for 66 elucidating various aspects of biofilm physiology, morphology, growth dynamics and antibiotic 67 and properties, the design of the CDC reactor system is such that coupons can be placed in 70 holding rods ( Figure 1A ). This allows for exposure to shear force and renewable nutrients that 71 optimize biofilm formation by simulating natural environments such as rivers, streams, oral 72 cavities, biomedical device surfaces or industrial systems (Costerton et al. 1978 reactor was developed such that it could hold coupons made of highly porous, bioabsorbable 83 collagen ( Figure 1B) . The rationale for doing so was two-fold. 84
First, there is currently a paucity of data on antibiotic efficacy against biofilms that are 85 grown on biologically relevant materials. Collagen constitutes 75% of the dry weight of human 86 skin, and is a major component of extracellular matrix and multiple tissue types that have 87
To make the collagen plugs, medical grade Collaform collagen was purchased as 1 cm x 136 2 cm plugs. The collagen was aseptically removed from packaging and cut into coupons with a 137 sterile blade. Coupon size was 1 cm diameter x 0.3 cm height. Coupons were aseptically loaded 138 into modified reactor arms ( Figure 1B ) that had already been autoclaved. The collagen coupons 139 remained securely in place when exposed to the shear forces in the reactor. Set up of each reactor 140 was performed inside a sanitized biosafety cabinet. 141
Biofilm Growth 142 143
From a fresh culture, a 0.5 McFarland standard of each bacteria was made, which equated 144 to ~7.5 x 10 7 colony forming units (CFU)/mL. One mL of the 0.5 McFarland solution was 145 inoculated into 500 mL of BHI in the CDC biofilm reactor. The reactor was placed on a hot plate 146 set at 34° C and a baffle rotation of 130 rpm for 24 h. After the 24 h batch growth, a continuous 147 flow of 10% BHI was flowed through the reactor at ~6.9 mL/min for an additional 24 h for a 148 total of 48 h of growth. 149
Baseline Quantification 150 151
To obtain a baseline of biofilm/coupon, two holding arms were aseptically removed from 152 a reactor and rinsed in 1x PBS. An n=6 coupons were individually placed in a test tube that 153 contained 2 mL CAMHB, vortexed for 1 min, sonicated for 10 min, then vortexed a final time 154 for approximately 10 sec. A 10-fold dilution series was used to plate bacteria in duplicate on 155 tryptic soy agar (TSA). Agar plates were incubated overnight at 37° C. CFU were counted and 156 used to calculate the CFU/coupon. 157
Antibiotic Treatment 158
Prior to assessing the antibiotic susceptibility of biofilms, the minimum inhibitory 159 concentration (MIC) of each antibiotic was determined against each bacterial strain (see Table  160 2). For all antibiotics, except amoxicillin and erythromycin against Streptococcus mutans, a 161 modified protocol of the Clinical and Laboratory Standards Institute (CLSI) guideline M100 was 162 used. In short, using a fresh overnight culture of bacteria, a 0.5 McFarland standard was made in 163 PBS using a nephelometer. The stock solution was diluted in PBS 1:100 to achieve a 164 concentration of ~7.5 x 10 5 CFU/mL. A 96-well plate was set up such that a final volume of 100 165 µL was present in each well. Column 1 served as the negative control of growth (antibiotic only 166 without bacteria added) and Column 11 served as the positive control of growth (bacteria only, 167 no antibiotic). 168
To accomplish this, 100 µL of CAMHB that contained antibiotic only (64 µg/mL) was 169 pipetted into each well of column 1 to serve as the negative control. Into columns 2-11, 50 µL of 170 CAMHB were added to each well. Subsequently, 50 µL of CAMHB that contained a 171 concentration of 256µg/mL antibiotic were added to each well of column 2 using a multi-channel 172 pipet. The solution was mixed, and then 50 µL were removed and added to wells of column 3. 173
This 1:2 dilution process was continued until column 10 and resulted in a range of antibiotic 174 testing from 64 µg/mL to 0.0625 µg/mL. Lastly, into each well of columns 2-11, 50 µL of the 175 bacterial solution were added, with column 11 serving as the positive control. The 96-well plate 176 was covered with adhesive film and incubated 24 h at 37° C. The concentration of antibiotic that 177 inhibited pellet formation or turbidity at the 24 h time point was considered the MIC. Once the 178 MIC was determined, biofilm analysis was performed. 179
To determine the MIC of amoxicillin and erythromycin against S. mutans, an E-Test was 180 used. In short, S. mutans was cultured on BHI agar and incubated for 48 hours under 5% CO2. A 181 1.0 McFarland standard solution was made in PBS resulting in 2.8 x 10 8 CFU/mL solution. This 182 was used to make lawns of bacteria on BHI agar by stroking back and forth with an inoculated 183 Q-tip in three directions. After drying, E-Test strips for each compound were laid (n=2 per plate, 184 2 plates per compound). The plates were incubated for 24 hours under 5% CO2 and then analyzed 185 per manufacturer's instructions. 186
Following a reactor run, n=5 polycarbonate and n=6 collagen coupons were aseptically 187 removed from a reactor, rinsed in 1x PBS, and each coupon was individually placed in a test tube 188 that contained 2 mL solution of antibiotic in CAMHB. Each of the antibiotics were tested 189 initially at 50, 100, and 200 µg/mL concentrations. In some instances, data spread needed to be 190
resolved so additional concentrations were tested down to 25 or up to 400, or 600 µg/mL. 191
Coupons were incubated for 24 h after which time each was quantified as described above. 192 193 194 Scanning electron microscopy (SEM) imaging was used to directly observe biofilm 195 morphology and confirm growth on both coupon types. To perform SEM imaging, biofilms were 196 grown following the same protocol as above. Notably, coupons used for SEM imaging to assess 197 morphology were not the same coupons used for the antibiotic testing. This was not possible 198
Scanning Electron Microscopy Imaging
given the need to fix and process biofilms, which inherently leads to cell death and would have 199 skewed the antibiotics or baseline quantification data. 200
To process for SEM imaging, a holder was aseptically removed from a reactor, rinsed one 201 time in 1x PBS, and each coupon was individually submerged in modified Karnovsky's fixative 202
(2.5% glutaraldehyde and 4% formaldehyde in 0.2 M PBS, pH 7.4) for ~1 h. The fixed 203 specimens were dehydrated in 100% ethanol for ~1 h, and then air-dried for ~30 min. 204
Coupons were placed on an SEM stage and secured using double-sided carbon tape, then 205 coated using a Hummer 6.2 gold sputter coater (Anatech LTD). All coupons were imaged with a 206 JEOL JSM-6610 SEM in secondary electron emission mode. 207
In addition to assessing biofilm morphology, because a combination of vortexing and 208 sonication was used to remove/disrupt biofilms as part of the baseline and treatment studies, it 209 was important to confirm that the vortex and sonication process did in fact remove the large 210 majority of biofilm from the surface of the coupons. After a thorough literature review, removal 211 of biofilms from collagen using vortex and sonication does not appear to have been confirmed 212 previously. Thus, for each bacterium, biofilms were grown on both materials, samples were 213 rinsed, vortexed, and sonicated as described, and were imaged by SEM (n=3) to determine if that 214 procedure effectively removes biofilm for an accurate quantification. 215
Lastly, in order to compare surface morphologies of the collagen and polycarbonate 216 coupon materials without bacteria on them, n=3 new and unused (negative control) coupons were 217 soaked in 10% BHI for 48 hrs. Coupons were then aseptically removed and processed as 218 described above for SEM imaging. 219
Statistical Analysis 220
Outcome measures (i.e. bacterial counts) were analyzed using an independent sample t 221 test for comparisons with alpha level set at 0.05 throughout. 222
Results 223
Biofilm Growth/SEM Imaging 224 SEM images showed that the collagen material alone was amorphous with a polymeric 225 strand network that had deep crevices throughout (Figure 2A vortex/sonication, the levels of biofilm that were present initially were far more than any other 262 isolate (see Figures 3-7) . Thus, the reduction was still significant. Based on surface area 263 coverage and reduction of the biofilm layers to a monolayer of cells, it was estimated that less 264 than 5% of cells remained on the surface after vortexing and sonication. 265
Baseline Quantification and Antibiotic Treatment 266
Quantification data of untreated coupons (positive controls of growth) is reported in 267 Table 1 . Of the ten isolates examined, six had growth profiles on collagen versus polycarbonate 268 that were statistically significantly different (Table 1 ). In each case where there was a difference, 269 more growth was present on collagen compared to polycarbonate (Table 1) . 270
MICs for each antibiotic against the bacterial species are reported in Table 3 . 276
Biofilms of S. aureus ATCC 6538 grown on collagen or polycarbonate were minimally 277 affected by ciprofloxacin, but did show a statistically significant difference with biofilms on 278 collagen having lower reduction than those on polycarbonate at 200 µg/mL (p=0.001; see Table  279 3). Susceptibilities were the same when exposed to cefazolin across a range of concentrations 280 (Table 3; p>0.3 in both cases). In this data set, the hypothesis was supported in one instance with 281 ciprofloxacin, but in no cases with cefazolin. 282
In the case of P. aeruginosa ATCC 27853, there was an approximately 4-5 Log10 283 reduction following exposure to ciprofloxacin at 50, 100, and 200 µg/mL (Table 3) . 284
Susceptibility of biofilms to ciprofloxacin on collagen was significantly less compared to those 285 on polycarbonate (e.g., p=0.03 at 200 µg/mL). Biofilm susceptibility to tobramycin had similar 286 outcomes. Tobramycin resulted in a 4-5 Log10 reduction at 50 µg/mL and complete kill at 100 287 µg/mL for both coupon types, with susceptibility being greater on polycarbonate coupons 288 compared to collagen (Table 3 ; e.g., p=0.046 at 50 µg/mL). The hypothesis was supported with 289 both antibiotics in this data set. 290
Biofilms of E. coli ATCC 9637 had the most notable differences in susceptibility profiles 291 between collagen and polycarbonate growth (Table 3 ). In all data sets, both ciprofloxacin and 292 ceftriaxone were more effective against biofilms on polycarbonate than those on collagen with 293 ceftriaxone having more polarized effect than ciprofloxacin (Table 3) . Differences between 294 collagen and polycarbonate testing were all statistically significantly different. As a 295 representative example, p=0.001 for ciprofloxacin at 100 µg/mL. The hypothesis was most 296 strongly supported in this data set, in particular with ceftriaxone. 297
Biofilms of A. baumannii ATCC BAA 1605 were highly susceptible to colistin, with an 8 298 Log10 reduction (undetectable growth) on both collagen and polycarbonate coupons at 100 299 µg/mL, and near complete kill at 200 µg/mL (Table 3) . The difference in CFU/coupon was 300 significantly different from baseline controls (p<0.005 in all cases), but there was no statistically 301 significant difference in the number of CFU/coupon between coupon types treated with colistin 302 at 50 µg/mL (p=0.371). These results indicated that efficacy of colistin against A. baumannii 303 biofilms was similar on both material types. Imipenem had minimal effect on biofilms on either 304 material type up to 200 µg/mL, and indicated that biofilm susceptibility was similar on both 305 materials (p=0.590). The hypothesis was not supported in any case for A. baumannii and the 306 antibiotics tested. 307
Biofilms of B. subtilis ATCC 19659 were found to be more susceptible to vancomycin on 308 polycarbonate than collagen (Table 3 ; e.g., p=0.001 at 100 µg/mL). Although there was no 309 detectable growth of biofilms on polycarbonate exposed to vancomycin at 100 µg/mL, an 310 anomaly was observed on polycarbonate coupons treated with vancomycin at 200 µg/mL; two of 311 five coupons had growth. The experiment was repeated with similar outcomes, resulting in a 312 large standard deviation at that concentration ( Table 3 ). At concentrations above 50 µg/mL, the hypothesis was 318 supported for both antibiotics tested in this data set. 319
In the case of MRSA USA 300, daptomycin was more effective at eradicating biofilms 320 on polycarbonate compared to collagen (p<0.001 in all cases), in particular at 400 µg/mL (Table  321 3). Vancomycin was nearly ineffective against biofilms on collagen (see Table 3 ) and reduced 322 biofilms on polycarbonate coupons to a much greater degree (e.g., p=0.002 at 400 µg/mL). 323
Similar to USA300 data, daptomycin was more effective at eradicating MRSA USA 400 324 biofilms on polycarbonate compared to collagen (e.g., p=0.003 at 100 µg/mL). Biofilms on 325 collagen showed no significant reduction by vancomycin at any concentration (Table 3 ) and on 326 polycarbonate showed a reduction of approximately 1.5 Log10 units by vancomycin at 100 µg/mL, 327 which was significant (p=0.001). Outcomes indicated that vancomycin was more effective at 328 eradicating MRSA USA 400 biofilms on polycarbonate compared to collagen. 329
Biofilms of S. mutans ATCC 25175 on collagen and polycarbonate showed no significant 330 reduction from baseline growth and no difference when exposed to 200 µg/mL erythromycin 331 (p=0.198), indicating that erythromycin was equally ineffective at eradicating S. mutans biofilm 332 on both material types. Biofilms on collagen were minimally affected by amoxicillin (Table 3. 
) 333
However, biofilms on polycarbonate showed significant reductions of approximately 2.5 Log10 334 units by amoxicillin at all concentrations (e.g., p=0.001 at 200 µg/mL). These data indicated that 335 amoxicillin was more effective at eradicating S. mutans biofilm on polycarbonate compared to 336 collagen, which contrasted the results of erythromycin. Thus, outcomes with amoxicillin 337 supported the hypothesis, whereas erythromycin did not. 338
Biofilms of S. epidermidis ATCC 35984 showed minimal reduction against biofilms on 339 collagen or polycarbonate when treated with vancomycin, indicating that vancomycin was 340 equally ineffective at eradicating S. epidermidis biofilms on both material types. Biofilms on 341 collagen showed a reduction of approximately 1.5 Log10 units by ciprofloxacin at 100 µg/mL and 342 approximately 2.5 Log10 units at 200 µg/mL (Table 3) . Biofilms on polycarbonate were reduced 343 by approximately 2.5 Log10 units with ciprofloxacin at 100 µg/mL and approximately 3 Log10 344 units at 200 µg/mL. There was a statistical difference between collagen and polycarbonate 345 outcomes with ciprofloxacin (e.g., p=0.004 at 200 µg/mL). Thus, data indicated that 346 ciprofloxacin was more effective against S. epidermidis biofilms on polycarbonate compared to 347 those on collagen. Outcomes supported the hypothesis with ciprofloxacin, but not vancomycin. 348
In the case of K. pneumoniae ATCC BAA-1705, ceftriaxone and imipenem/cilastatin had 349 minimal effect against biofilms on collagen or polycarbonate. There was about 1 Log10 more 350 bacteria that grew on collagen compared to polycarbonate. In all cases, there were more bacteria 351 on coupons in treatment groups than there were on positive controls. These data neither 352 supported nor unsupported the hypothesis as the isolate was resistant to both antibiotics, yet were 353 included to provide a comparison of outcomes when susceptibility was not present. 354
Taken together, data indicated that in 13/18 cases the hypothesis was supported. K. 355 pneumoniae data were not included in the outcome as biofilms treated with antibiotics had more 356 growth than positive controls. 357
Discussion 358
Biofilms can be grown on a wide variety of surfaces, materials and exposed to myriad 359 environmental conditions. One of the most common reactor systems to grow biofilms is the CDC 360 biofilm reactor, which is beneficial in that it is a robust system that can be modified to hold a 361 The rationale was, there is significant literature on susceptibility profiles of biofilms grown on 368 hard, relatively smooth polymer surfaces, but a paucity of data for susceptibility on more 369 complex, biologically-relevant materials such as collagen. Yet it is important to understand 370 susceptibility profiles given that clinical antibiotics used in human applications may find utility 371 in targeting biofilms that have significant and direct contact with soft and hard tissue, a primary 372 constituent of which is collagen (Fratzl et al. 2004 , Lovell et al. 1987 , Neuman and Logan 1950 . 373
One component of the study was to determine whether bioabsorbable collagen would 374 dissolve/disintegrate in the modified CDC biofilm reactor. Results indicated that the collagen did 375 not dissolve/disintegrate within the time frame of growth. Indeed, additional data further 376 suggested that collagen was stable to culture conditions for as long as 8 days in the reactor. This 377 demonstrated that growth on bioabsorbable collagen could be performed in the CDC reactor and 378 allows for future applications of this collagen biofilm system toward in vitro and in vivo 379 applications. For example, in a diabetic pig wound study, biofilms are currently being grown on 380 collagen coupons for inoculation and analysis. 381
Biofilm susceptibility data indicated that in the majority of instances (13/18), the general 382 hypothesis-that biofilms grown on polycarbonate would be more susceptible to antibiotics than 383 those grown on collagen-was supported. Pairings that supported the hypothesis were 384 ciprofloxacin at 200 µg/mL against S. aureus ATCC 6538, tobramycin and ciprofloxacin against 385 Pairings that did not support the hypothesis were cefazolin against S. aureus ATCC 6538, 390 colistin and imipenem against A. baumannii ATCC BAA 1605, erythromycin against S. mutans 391 ATCC 25175, and vancomycin against S. epidermidis ATCC 35984. Carbapenem-resistant K. 392 pneumoniae ATCC BAA 1705 was resistant to both ceftriaxone and imipenem/cilastatin. 393
Baseline quantification data indicated that for five of the ten isolates, both coupon types 394 had similar amounts of biofilm. The five that did not were, E. coli, MRSA USA300, MRSA 395 USA400, S. mutans, and K. pneumoniae, which formed biofilms more readily and to a greater 396 degree on collagen coupons compared to polycarbonate. In four of those cases (E. coli, MRSA 397 300, MRSA 400, and S. mutans), reduction of biofilms on polycarbonate coupons was 398 significantly greater than on collagen coupons by one or both antibiotics. These data highlighted 399 the importance of confirming efficacy profiles of antibiotics against biofilms on material types 400 that may be relevant to a given application. As in the majority of instances biofilms were more 401 tolerant to antibiotics on collagen than on hard surface polycarbonate, for applications of clinical 402 relevance, it may be beneficial to assess antibiotic biofilm efficacy profiles against an isolate(s) 403 in the presence of biologically relevant materials. 404
Limitations of the study included a single time of biofilm growth (48 hr). This was 405 consistent with published standards. However, future work could include the addition of growing 406 biofilms for a longer period of time to increase maturity. Biofilms that develop over a longer 407 period of time may more closely replicate biofilms in clinical environments and thus potentially 408 influence susceptibility profiles (Wolcott et al. 2010) . Time and concentration of antibiotic 409 exposure can also be analyzed in future work to determine what influence these have on more 410 significant eradication of biofilms. 411
Taken together, data from eight isolates (thirteen isolate/antibiotic pairings) supported the 412 hypothesis, that susceptibility to antibiotic would be greater on polycarbonate coupons compared 413 to collagen. In the case of A. baumannii ATCC BAA 1605, antibiotics were able to eradicate 414 biofilms to the same degree whether grown on collagen or polycarbonate coupons. K. 415 pneumoniae ATCC BAA 1705 was excluded from susceptibility analysis as it was resistant to 416 the antibiotics tested. 417
Higher concentrations of antibiotic were not tested given that the primary outcome 418 measure was to determine if susceptibility was similar on two material types, not to determine 419 the concentration of antibiotic that would reduce biofilms to a specific level. Although the 420 reduction of biofilms was not a primary outcome measure, if data were to be applied to clinically 421 relevant paradigms, this would be an important and application-dependent factor. 422
In conclusion, susceptibility of biofilms to antibiotics was significantly different in the 423 majority of instances following 48 h of growth on biologically relevant collagen or 424 polycarbonate material. Although there are only speculative reasons why some antibiotic-425 bacterial pairing produce significant differences in biofilm susceptibility on different substrates, 426 this study demonstrates that there can be differences in susceptibility. On a go-forward basis, 427 these data are valuable for advancing information on antibiotic susceptibility testing of biofilms 428 grown on a variety of material types and encourage the independent evaluation of susceptibilities 429 Surface of collagen with biofilm growth. Biofilm structure resulted in uniform coverage, but did 571 not appear to plume as other staphylococcal isolates did. Rather, MRSA USA 400 displayed 572
sheet-like growth on collagen. (D-F) Surface of a polycarbonate coupon that had sparse 573 coverage, although where biofilm did form, it plumed to an estimated 30 cell layers thick. Arrow 574 (panel F) indicates a biofilm plume. 575 576 577 Images of residual cells on collagen after vortex and sonication. Data indicated that biofilms 587 were effectively disrupted/removed with >5% of cells remaining on the surface. 588 589 the large majority of biofilm burden had been removed by vortex/sonication, but clusters of cells 593 still remained. (D) Similar to collagen, large plumes of biofilms formed on polycarbonate 594 coupons with deep ravines. Although these ravines may have formed during the dehydration 595 procedure, it is likely they were sites of water channels that provided fracture points within the 596 biofilm communities. (E-F) Images showed that there was still a fair amount of surface coverage 597 by biofilms post-vortex/sonication. However, it was estimated that there were >5% of cells 598 remaining on the surface similar to other bacterial isolates examined. 599 600 
